Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Juno Therapeutics Shares Are Going Up 21.2% Today

TheMotleyFool

0 0

Why Juno Therapeutics Shares Are Going Up 21.2% Today

After the company released its third-quarter progress report and shared the latest data from its lead drug, JCAR017, shares of Juno Therapeutics (NASDAQ: JUNO) are shooting 21.2% higher at 2:30 p.m. EDT today.

There weren't any surprises in Juno Therapeutics' earnings release. Its collaboration revenue in the quarter was $44.8 million and, unsurprisingly, major research and development spending resulted in a loss of $0.73 per share.

IMAGE SOURCE: GETTY IMAGES.

Source: Fool.com